Siemens Healthineers mammography reading software planned to include AI-based decision support

Published on: November 26, 2018 | More about Siemens Healthineers

During the 104th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), Nov. 25-30 at Chicago’s McCormick Place, Siemens Healthineers showcases the new planned AI-based features with its mammography reading and reporting solution, syngo.Breast Care.1 These features are designed to provide physicians with interactive decision support.

AI features can help assist clinicians, particularly in cancer screening. A large number of mammograms are performed each day to screen for breast cancer, which means radiologists must accurately interpret hundreds of images daily. Additionally, the increased use of 3D breast tomosynthesis adds to the number of images to be read. The new version of syngo.Breast Care is designed to give radiologists interactive clinical decision support.

AI-based algorithms are designed to help evaluate individual lesions and provide a system evaluation for 2D mammograms or tomosynthesis. A peer-reviewed scientific study2 demonstrated increased sensitivity and specificity with the use of AI-based support.

Also, the planned software is designed to sort cases automatically and score those cases with a numerical value between 1 and 10. The case score is designed to take into account any existing lesions, microcalcifications, and other abnormalities.

syngo.Breast Care’s planned new SmartSort technology is designed for radiologists to rank exams according to their preferences based on these case scores. For example, critical cases can be moved immediately to the top to receive priority.

Siemens Healthineers collaborated with ScreenPoint Medical and plans to integrate interactive decision support in syngo.Breast Care. The company’s mammography reading software, Transpara,³ is based on deep learning and has been trained with over 1 million images.

¹ Syngo.Breast Care VB40 - powered by Transpara™, ScreenPoint Medical - is currently under development. It is not for sale in the U.S. Its future availability cannot be guaranteed.

2 Rodriguez-Ruiz A., Gubern-Merida A., Lang K., et al.: Detecting breast cancer in mammography: a deep learning-based computer system versus 101 radiologists (RSNA abstract 2018).

³ Transpara is currently 510(k) pending for 2D reading.

Around the web

Cardiovascular Business

Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business

‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

Cardiovascular Business

FDA clears AI tool that flags signs of heart disease in chest CT scans

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer.